Table 1. Genomic aberrations in MYCN/Alk tumors defined by array-CGH. Abnormalities are indicated for each tumor together with the genotype, genetic background, sex and age of the mouse. 129B6F1: F1 background from 129×1/SvJ × C57Bl6/N intercrosses.

Tumor	Genotype	Genetic background	Sex	Age in days	Abnormalities in CGH
tumor 31	MYCN / KI AlkF1178L	129S2	F	36	0
tumor 28	MYCN / KI AlkF1178L	129S2	M	37	0
tumor 29	MYCN / KI AlkF1178L	129S2	F	44	0
tumor 30	MYCN / KI AlkF1178L	129S2	M	36	0
tumor 13	MYCN / KI AlkR1279Q	129S2	M	67	0
tumor 14	MYCN / KI AlkR1279Q	129S2	M	75	0
tumor 16	MYCN / KI AlkR1279Q	129S2	M	59	0
tumor 18	MYCN / KI AlkR1279Q	129S2	M	58	0
tumor 19	MYCN / KI AlkR1279Q	129S2	M	59	0
tumor 2	MYCN / KI AlkF1178L	129B6F1	M	133	2- 4- 3+ 6+ 12+ 13- 14- 16-
tumor 1	MYCN / KI AlkF1178L	129B6F1	M	133	11+
tumor 4	MYCN / KI AlkF1178L	129B6F1	F	91	3+ 17+
tumor 11	MYCN / KI AlkF1178L	129B6F1	F	98	0
tumor 38	MYCN / KI AlkF1178L	129B6F1	F	134	3+5-15q-16-
tumor 37	MYCN / KI AlkF1178L	129B6F1	M	64	0
tumor 8	MYCN / KI AlkR1279Q	129B6F1	F	181	4-5-6+10+12+13-14-17+19-
tumor 5	MYCN / KI AlkR1279Q	129B6F1	F	116	4- 4qA3+15qE2-
tumor 9	MYCN / KI AlkR1279Q	129B6F1	M	190	2q+11q+ 15qF3-